PSNL
Personalis Inc
NASDAQ: PSNL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.04
-8.36% today
Updated 2026-04-29
Market cap
$575.73M
P/E ratio
—
P/S ratio
8.27x
EPS (TTM)
$-0.91
Dividend yield
—
52W range
$4 – $12
Volume
1.6M
Personalis Inc (PSNL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-116.70%
Operating margin
-145.70%
ROE
-35.00%
ROA
-18.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $9.39M | $-23.60M | -24.94% | -235.95% | -251.23% |
| 2018 | $37.77M | $-19.89M | 31.25% | -36.45% | -52.64% |
| 2019 | $65.21M | $-25.08M | 33.86% | -34.38% | -38.47% |
| 2020 | $78.65M | $-41.28M | 25.57% | -53.59% | -52.49% |
| 2021 | $85.49M | $-65.23M | 37.03% | -76.44% | -76.29% |
| 2022 | $65.05M | $-113.31M | 20.52% | -177.61% | -174.20% |
| 2023 | $73.48M | $-108.30M | 24.78% | -149.61% | -147.38% |
| 2024 | $84.61M | $-81.28M | 31.70% | -80.68% | -96.06% |
| 2025 | $69.65M | $-81.27M | -77.35% | -126.43% | -116.69% |